When animals were given rosuvastatin both NLRP3 inflammasome and MAPK expression was decreased, with associated decrease in cardiac fibrosis, suggesting a potential role for the NLRP3 inflammasome in diabetic cardiomyopathy. This evidence concerns the gene NLRP3 and fibrosis.